We have read with great interest the report by Marshall et al. regarding the efficacy of the combination of ceftazidime-avibactam (CAZ-AVI) and aztreonam (ATM) against metallo-β-lactamase-producing Enterobacteriaceae ([1][1]). These results confirm our experience with two patients treated with CAZ
No takes yet. Share an insight, caveat, or question.
Davido et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: